Listen

Description

I. Case Context

A 61-year-old hypertensive male scheduled for elective laparoscopic inguinal hernia repair undergoes preoperative transthoracic echocardiography.
He is asymptomatic, with good effort tolerance (≈6 METs), controlled blood pressure, and no prior cardiac disease.
The echocardiogram reveals:

This represents a compensated, pressure–volume–adaptive heart, typical of patients presenting for elective surgery with chronic hypertension and age-related valve sclerosis.

II. Systematic Approach to Reading an Echocardiogram for Anesthesia

An anesthesiologist must extract three key pieces of information from an echo report:

  1. How strong the heart pumps (systolic function)

  2. How well it fills (diastolic function)

  3. What impedes or leaks the flow (valvular and pressure pathophysiology)

Each parameter on the report contributes to one of these three physiologic domains.
Echocardiography therefore serves as a dynamic hemodynamic map—a noninvasive reflection of preload, afterload, contractility, and compliance.

Table 1. Stepwise Framework for Echo Interpretation

Teaching Pearl

“A good anesthesiologist reads an echo the way a pilot reads a cockpit—every number tells a part of the flight story.”

III. Chamber Geometry and Wall Thickness

Interpretation

Concentric LVH signifies chronic pressure overload—most commonly due to systemic hypertension or aortic outflow resistance.
The hypertrophied myocardium contracts well (normal EF), but becomes stiff during relaxation, leading to diastolic dysfunction.

Clinical Implication for Anesthesia:

Mechanistic Insight

Teaching Pearl

“LVH is the price a ventricle pays for surviving high blood pressure.”
It’s strong but less forgiving—don’t let it run dry or overfilled.

References

  1. Ganau A, et al. Patterns of left ventricular hypertrophy and clinical outcomes. J Am Coll Cardiol. 1992;19(7):1550–8.

  2. Marwick TH. Echocardiographic assessment of LVH in the perioperative period. Br J Anaesth. 2021;127(1):69–78.

  3. Grossman W, et al. Cardiac hypertrophy: cellular and molecular...